This volume of Frontiers in Clinical Drug Research - Dementia explores the current comorbidities that cause cognitive impairment and the current management alternatives for clinical cases of dementia. The reviews contributed in these volume will provide readers with a current perspective on the subject. The topics covered in this volume include:
- Comorbidities inducing mild cognitive impairment - an evaluation of the risk caused by some pathological conditions
- Tau-targeted therapy in Alzheimer's disease - history and current state
- Emerging nanotherapeutic strategies in Alzheimer's disease
- Implication of dehydroepiandrosterone on dementia related to oxidative stress
- Polyphenol compounds as potential therapeutic agents in Alzheimer’s disease
The volume is a timely update on dementia treatment for clinical physicians, neurologists, gerontologists, pharmaceutical and medicinal chemistry researchers, and physiologists.
Editor:
Dr. José Juan Antonio Ibarra Arias
Keywords:
Dysbiosis, Hypertension, Long-Term Potentiation, Low-Grade Inflammation, Mild Cognitive Impairment, Neurogenesis, Non-Amnestic Memory, Spinal Cord Injury, Alzheimer’s disease, Anti-tau therapy, Microtubules, Tau protein, Dehydroepiandrosterone, Dehydroepiandrosterone Sulphate, Oxidative, Stress, Neuroprotection, Reactive Oxygen Species, Steroids.
For More Information, Please visit: https://bit.ly/3D21sct